Concourse Financial Group Securities’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5491 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6355 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6349 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6368 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6365 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6296 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6161 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6016 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5799 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5795 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5616 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5593 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5488 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5493 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5341 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5169 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5021 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4890 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4693 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4564 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4550 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4487 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4281 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4465 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4405 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4282 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4005 |
|